Assembly Biosciences (ASMB) Tax Provisions (2016 - 2025)
Assembly Biosciences (ASMB) posted quarterly Tax Provisions of -$76000.0 for Q4 2024, down 330.3% year-over-year from $33000.0 in Q1 2024, and down 118.72% quarter-over-quarter from $406000.0 in Q2 2024.
Assembly Biosciences (ASMB) Tax Provisions (2016 - 2025) Analysis & Trends
Assembly Biosciences' Tax Provisions history runs 6 years deep, the most recent figure standing at -$76000.0 for Q4 2024.
- In Q4 2024, Tax Provisions fell 330.3% year-over-year to -$76000.0; the TTM figure through Dec 2025 stood at -$76000.0 (down 120.94% YoY), while the FY2024 annual figure was $330000.0, up 900.0% from the prior year.
- Tax Provisions for Q4 2024 stood at -$76000.0, down from $406000.0 in the prior quarter.
- The five-year high for Tax Provisions was $406000.0 in Q2 2024, with the low at -$76000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.40 Mn |
| Dec 31, 2024 | -76,000.00 |
| Jun 30, 2024 | 406,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Dec 31, 2019 | -741,000.00 |
| Sep 30, 2019 | -15,000.00 |
| Jun 30, 2019 | -11,000.00 |
| Mar 31, 2019 | -7,000.00 |
| Dec 31, 2018 | 40,000.00 |
| Sep 30, 2018 | -6,000.00 |
| Jun 30, 2018 | -34,000.00 |
| Dec 31, 2017 | 105,416.00 |
| Sep 30, 2017 | -35,903.00 |
| Jun 30, 2017 | -69,513.00 |
| Dec 31, 2016 | -618,000.00 |